Loading company details...
Beta
Latest Form 4 (Oct 15, 2026): Andrew J. Murphy (Co-Chief Scientific Officer): Exercise/Conversion of 17,000 shares, $6.49M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 15, 2026 | Andrew J. Murphy, Co-Chief Scientific Officer | Exercise/Conversion | 17,000 | $6.49M |
| Sep 3, 2026 | Marion McCourt, EVP Commercial | Sale | 1,215 | $1.03M |
| Sep 3, 2026 | Kathryn Guarini | Exercise/Conversion | 400 | $287.7K |
| Aug 21, 2026 | Joseph J. Larosa, EVP General Counsel and Secret | Exercise/Conversion | 12,282 | $4.69M |
| Aug 20, 2026 | Christopher R. Fenimore, EVP Finance CFO | Exercise/Conversion | 6,283 | $2.40M |
| Aug 12, 2026 | Kathryn Guarini | Exercise/Conversion | 400 | $287.7K |
| Aug 12, 2026 | Huda Y. Zoghbi | Exercise/Conversion | 800 | $301.4K |
| Jul 7, 2026 | Arthur F. Ryan | Sale | 200 | $130.0K |
| May 4, 2026 | Arthur F. Ryan | Sale | 5 | $3.5K |
| Apr 3, 2026 | Arthur F. Ryan | Sale | 1 | $771.32 |